Loading...
OptimizeRx Corp (OPRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, the financial performance shows declining net income and EPS, and there are no significant positive catalysts or trading signals. While the company's revenue growth is promising, the lack of strong momentum and sentiment suggests holding off on investment until clearer opportunities arise.
The technical indicators for OPRX are bearish. The MACD histogram is negative and contracting, RSI is neutral at 34.473, and moving averages suggest a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 8.22, with key support at 7.341 and resistance at 9.099.

Revenue increased by 22.33% YoY in Q3 2025, and gross margin improved by 8.76% YoY to 63.05%.
The MACD and moving averages indicate a bearish trend. No significant insider or hedge fund trading activity. No recent congress trading data or influential figure activity. No AI Stock Picker or SwingMax trading signals.
In Q3 2025, revenue increased to $26.07M (up 22.33% YoY), but net income dropped to $779K (-108.54% YoY), and EPS fell to 0.04 (-108.00% YoY). Gross margin improved to 63.05% (up 8.76% YoY).
No data available for analyst ratings or price target changes.